MGPI vs PG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MGPI presents a classic 'value trap' profile: fundamentally healthy but operationally declining. While the Piotroski F-Score of 7/9 indicates strong financial health and the balance sheet is robust (Debt/Equity 0.37), the company is facing a severe growth crisis with revenue down 23.5% and EPS down 59.9% YoY. The stock is deeply undervalued on a Price-to-Book (0.57) and Price-to-Sales (0.77) basis, but this is offset by bearish insider activity and a nearly unsustainable dividend payout ratio of 96%.
PG shows neutral fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
MGPI vs PG: Head-to-Head Comparison
This page compares MGP Ingredients, Inc. (MGPI) and The Procter & Gamble Company (PG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.